TherapeuticsMD | TXMD - Assets

Stock Price
2.33
Daily Change
0.04 1.53%
Monthly
2.88%
Yearly
130.20%
Q1 Forecast
2.17

TherapeuticsMD reported $40.13M in Assets for its fiscal quarter ending in June of 2024.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pfizer USD 208.73B 2.64B Sep/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024